Strategy on the Treatment of Steroid-Refractory Severe acute Graft-versus-Host Disease

被引：0
|
作者：
Yamin, T. [1 ]
Yi, L. [1 ]
Kaili, D. [1 ]
He, H. [1 ]
机构：
[1] Zhejiang Univ, Bone Marrow Transplantat, Hangzhou 310003, Zhejiang, Peoples R China
来源：
BONE MARROW TRANSPLANTATION | 2015年 / 50卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P547
引用
收藏
页码：S393 / S394
页数：2
相关论文
共 50 条
  • [31] Combination Therapy with Inolimomab and Etanercept for Severe Steroid-Refractory Acute Graft-versus-Host Disease
    van Groningen, Lenneke F. J.
    Liefferink, Aleida M.
    de Haan, Anton F. J.
    Schaap, Nicolaas P. M.
    Donnelly, J. Peter
    Blijlevens, Nicole M. A.
    van der Velden, Walter J. F. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (01) : 179 - 182
  • [32] COMBINATION THERAPY WITH INOLIMOMAB AND ETANERCEPT FOR SEVERE STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE
    Van Groningen, L.
    Liefferink, A.
    de Haan, A.
    Schaap, N.
    Donnelly, P.
    Blijlevens, N.
    van der Velden, W.
    HAEMATOLOGICA, 2015, 100 : 279 - 279
  • [33] Salvage therapy with basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease
    Freyer, Craig W.
    Gier, Shannon
    Carulli, Alison
    Gill, Saar I.
    Hexner, Elizabeth O.
    Loren, Alison W.
    Martin, Mary Ellen
    Porter, David L.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (07) : E273 - E276
  • [34] Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: A pilot study.
    Greinix, HT
    Volc-Platzer, B
    Knobler, RM
    Keil, F
    Worel, N
    Mitterbauer, M
    Schulenburg, A
    Hoecker, P
    Kalhs, P
    BLOOD, 2000, 96 (11) : 477A - 477A
  • [35] Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease
    Lennart Philippen
    Natalie Schub
    Andreas Günther
    Gunnar Cario
    Martin Schrappe
    Roland Repp
    Martin Gramatzki
    Bone Marrow Transplantation, 2024, 59 : 153 - 155
  • [36] Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease
    Philippen, Lennart
    Schub, Natalie
    Guenther, Andreas
    Cario, Gunnar
    Schrappe, Martin
    Repp, Roland
    Gramatzki, Martin
    BONE MARROW TRANSPLANTATION, 2024, 59 (01) : 153 - 155
  • [37] Ruxolitinib as a treatment option for steroid-refractory severe graft-versus-host disease - case report
    Paul, S.
    Wass, M.
    Mueller-Tidow, C.
    Mueller, L. P.
    Oncology Research and Treatment, 2015, 38 : 53 - 53
  • [38] Ruxolitinib for Steroid-Refractory Acute Graft-Versus-Host Diseas
    Toama, Wael
    Fiala, Mark A.
    Pusic, Iskra
    Westervelt, Peter
    DiPersio, John F.
    Schroeder, Mark A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [39] How I treat steroid-refractory acute graft-versus-host disease
    Martin, Paul J.
    BLOOD, 2020, 135 (19) : 1630 - 1638
  • [40] Outcomes and Predictors of Response in Steroid-Refractory Acute Graft-versus-Host Disease
    Rashidi, Armin
    DeFor, Todd E.
    Holtan, Shernan G.
    Blazar, Bruce R.
    Weisdorf, Daniel J.
    MacMillan, Margaret L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (11) : 2297 - 2302
12345